Transcript segment

Baric Transcribed Interview (Redacted), p.30 · baric_ti:utt:00176

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Christina Salazar, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Ralph S. Baric
Topics: Gain-of-function research Wuhan Institute of Virology collaboration

So in, was it, October 2014, the Obama administration put out the pause. The pause effectively was set up two ways. One way was that if a grant was submitted that had the potential for gain-of-function research it would be reviewed before they funded it. And the second class was if you were already doing P3, or research that might fall under the category, you had the option to either pause it voluntarily or continue it. And in the case of SHC014-WIV work, we paused it voluntarily. The third category was waivers. And so the NIH approved three groups, to my knowledge, to continue to develop a MERS coronavirus mouse model for countermeasured studies.

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
One way was that if a grant was submitted that had the potential for gain-of-function research it would be reviewed before they funded it.	quoted / not their view	hypothetical conditional framing	asserts

Statement

Grade

Attribution

Stance

One way was that if a grant was submitted that had the potential for gain-of-function research it would be reviewed before they funded it.

quoted / not their view

hypothetical conditional framing

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Ralph S. Baric open

Well, it wouldn't be the application. It would be a specialized series of documents associated with P3CO review. Again, this would have been very early on, too, so the formalized structure for that review wasn't, I think, finalized until '16 or '17, I think, with the NSABB stuff. DC.Scheduling@LexitasLegal.com
2026-04-10 09:00 Christina Salazar open

But there was a structure.
2026-04-10 09:00 Ralph S. Baric open

There certainly was a structure. They reviewed it, responded, and then asked for responses from me, and then I gave those responses.
2026-04-10 09:00 Christina Salazar open

And could you tell us a little bit about, at the time, what that process was like, in terms of the P3CO process?
2026-04-10 09:00 Ralph S. Baric

So in, was it, October 2014, the Obama administration put out the pause. The pause effectively was set up two ways. One way was that if a grant was submitted that had the potential for gain-of-function research it would be reviewed before they funded it. And the second class was if you were already doing P3, or research that might fall under the category, you had the option to either pause it voluntarily or continue it. And in the case of SHC014-WIV work, we paused it voluntarily. The third category was waivers. And so the NIH approved three groups, to my knowledge, to continue to develop a MERS coronavirus mouse model for countermeasured studies.
2026-04-10 09:00 Christina Salazar open

And you were one of them?
2026-04-10 09:00 Ralph S. Baric open

And we were one of them.
2026-04-10 09:00 Christina Salazar open

Do you know who the others were?
2026-04-10 09:00 Ralph S. Baric open

I think one group was out of the University of Utah. I can't remember the fellow's name.

Full conversation →